VD
Vinayak Dinesh Dendukuri
About Vinayak Dinesh Dendukuri
Data last updated:
Vinayak Dinesh Dendukuri is a Whole-Time Director at Bafna Pharmaceuticals Limited (since 2023), Director at Novick Bio-Sciences Private Limited (since 2016) and Director at Beltree Lifesciences India Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma, Packaging and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹163 Cr; the largest is Bafna Pharmaceuticals Limited at ₹149 Cr (FY 2025). Earlier, Vinayak Dinesh Dendukuri was a Director at Brane Services Private Limited (2020–2023) and Director at Brane Products Private Limited (2020–2023) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 26 Jun 2023 | 1995 | ₹149 Cr (FY 2025) | Active | |
| Director | 19 Sep 2016 | 2016 | ₹14.34 Cr (FY 2024) | Active | |
| Director | 27 Mar 2023 | 2022 | ₹9.5 Lakh (FY 2023) | Active | |
| Designated Partner | 14 Feb 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Aug 2020 | 2020 | ₹1.97 Cr (FY 2023) | Active | |
| Director | 04 Aug 2020 | 2020 | ₹88.7 Lakh (FY 2023) | Active | |
| Director | 06 Jul 2020 | 2020 | ₹47.50 Cr (FY 2023) | Active | |
| Director | 03 Sep 2019 | 2015 | Converted To Llp | ||
| Nominee Director | 25 Jul 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vinayak Dinesh Dendukuri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vinayak Dinesh Dendukuri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vinayak Dinesh Dendukuri
Vinayak Dinesh Dendukuri currently holds 4 directorships: Bafna Pharmaceuticals Limited (Whole-Time Director, since 26 Jun 2023, revenue ₹149 Cr (FY 2025)); Novick Bio-Sciences Private Limited (Director, since 19 Sep 2016, revenue ₹14.34 Cr (FY 2024)); Beltree Lifesciences India Private Limited (Director, since 27 Mar 2023, revenue ₹9.5 Lakh (FY 2023)); Sirius Unify Ventures Llp (Designated Partner, since 14 Feb 2025).
Vinayak Dinesh Dendukuri was first appointed on 19 Sep 2016 as Director at Novick Bio-Sciences Private Limited. The most recent appointment on record is 14 Feb 2025 at Sirius Unify Ventures Llp.
The 3 current companies of Vinayak Dinesh Dendukuri that report revenue have a combined latest revenue of ₹163 Cr: Bafna Pharmaceuticals Limited ₹149 Cr (FY 2025); Novick Bio-Sciences Private Limited ₹14.34 Cr (FY 2024); Beltree Lifesciences India Private Limited ₹9.5 Lakh (FY 2023).
Vinayak Dinesh Dendukuri held 5 earlier board appointments: Brane Services Private Limited (Director, 07 Aug 2020 to 20 Jul 2023); Brane Products Private Limited (Director, 04 Aug 2020 to 20 Jul 2023); Brane Enterprises Private Limited (Director, 06 Jul 2020 to 20 Jul 2023); Next-Spaces Ecobuild India Private Limited (Director, 03 Sep 2019 to 15 Dec 2019); Rasina Therapeuctics Private Limited (Nominee Director, from 25 Jul 2019).
The current boards of Vinayak Dinesh Dendukuri's companies include Akila Chintalapati Raju (Bafna Pharmaceuticals Limited), Ashok Barathi Mohanachandran (Bafna Pharmaceuticals Limited), Bafna Mahaveer Chand (Bafna Pharmaceuticals Limited), Melagiri Sridhar (Bafna Pharmaceuticals Limited), Palamadai Krishnan Sundaresan (Bafna Pharmaceuticals Limited), Ravichandran Chitra (Bafna Pharmaceuticals Limited), among others.